BRZE Form 4: CFO Sells 11,316 Shares at $25.94; Retains 267,550
Isabelle Winkles, Chief Financial Officer of Braze, Inc. (BRZE), sold 11,316 shares of Class A common stock on 08/19/2025 at $25.94 per share under a non-discretionary sell-to-cover program to satisfy tax withholding on vested restricted stock units.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Isabelle Winkles, Chief Financial Officer of Braze, Inc. (BRZE), sold 11,316 shares of Class A common stock on 08/19/2025 at $25.94 per share under a non-discretionary sell-to-cover program to satisfy tax withholding on vested restricted stock units. After the sale, the filing reports the reporting person beneficially owns 267,550 shares, of which 195,217 shares are represented by restricted stock units. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
Positive
- Reporting compliance: The transaction is disclosed on a Form 4 with sale date, price, and resulting beneficial ownership.
- Substantial post-transaction ownership: The reporting person retains 267,550 shares following the sale.
Negative
- Insider sale: 11,316 Class A shares were sold at $25.94 per share on 08/19/2025.
- Large portion held as RSUs: 195,217 of the reported shares are represented by restricted stock units, indicating future vesting-related tax events may trigger additional sell-to-cover actions.
Insights
TL;DR: Routine tax-related disposition by a company officer; ownership remains substantial.
The filing documents a sale of 11,316 Class A shares at $25.94 each executed on 08/19/2025 under a pre-established non-discretionary sell-to-cover program used to satisfy tax withholding on vested restricted stock units. The reporting person still beneficially owns 267,550 shares following the transaction, including 195,217 RSU-represented shares. This is a standard disclosure of insider selling tied to compensation vesting rather than an open-market discretionary sale.
TL;DR: Form 4 shows compliance with a Rule 10b5-1 style plan and clear reporting of post-transaction holdings.
The filing indicates the transaction was effected pursuant to a non-discretionary sell-to-cover program established by the issuer and last modified April 30, 2023, which the filer checked on the form. The disclosure includes the number of shares sold, sale price, and the resulting beneficial ownership, and the form is executed via attorney-in-fact. These elements align with typical Section 16 reporting practices for tax-withholding transactions tied to RSU vesting.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 11,316 | $25.94 | $294K |
Footnotes (2)
- F1. This transaction was effected in accordance with a non-discretionary sell-to-cover program implemented by the Issuer, effective November 16 ,2021 and last modified April 30, 2023, to satisfy tax withholding obligations arising in connection with the vesting of the Reporting Person's restricted stock units.
- F2. Of the reported shares, 195,217 shares are represented by restricted stock units.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did BRZE CFO Isabelle Winkles report on Form 4?
Why was the sale executed under a sell-to-cover program?
When was the sell-to-cover program established or last modified?
Who signed the Form 4 for Isabelle Winkles?
AI-generated analysis. How Rhea-AI works. Not financial advice.